Codexis (CDXS) Depreciation & Amortization (CF) (2010 - 2026)
Codexis (CDXS) posted quarterly Depreciation & Amortization (CF) of $1.3 million for Q1 2026, up 7.62% year-over-year from $1.2 million in Q1 2025, and down 5.23% quarter-over-quarter from $1.4 million in Q4 2025.
Codexis (CDXS) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Codexis' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 7.62% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $5.3 million (up 9.2% YoY), while the FY2025 annual figure was $5.2 million, up 6.11% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $1.3 million, down from $1.4 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $1.5 million in Q2 2023, with the low at $1.2 million in Q1 2025.
- The 5-year median for Depreciation & Amortization (CF) is $1.3 million (2025), against an average of $1.3 million.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) surged 87.29% in 2022, then decreased 15.61% in 2023.
- Codexis' Depreciation & Amortization (CF) stood at $1.4 million in 2022, then dropped by 15.61% to $1.2 million in 2023, then fell by 0.58% to $1.2 million in 2024, then climbed by 12.24% to $1.4 million in 2025, then decreased by 5.23% to $1.3 million in 2026.
- Business Quant data shows CDXS's Depreciation & Amortization (CF) at $1.3 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | 1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.21 Mn |
| Jun 30, 2026 | 1.21 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.25 Mn |